Light Mode
$1.08 ↑ +0.05 (+4.85%) Trading Up from the previous close of $1.03
+0.75 (+262.68%) / 6M
Momentum, market sentiment, and recent alerts
ICCM reads not so good: price sits below both the 20- and 200-day averages, the 12-month move is +29.7%.
Earnings, valuation, and balance sheet
Company profile and competitor comparison
IceCure Medical Ltd. engages in the development and marketing of therapy for the treatment of tumors. Its product, ProSense Cryoablation System, provides invasive treatment option to destroy tumors by freezing them. The company was founded in 2006 and is headquartered in Caesarea, Israel.
Real-time scanning and AI-generated signals across the entire market.
Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.